Latest news about the Akademie Fresenius

Endocrine Disruptors Conference 2026 in Cologne

Last week, it was our pleasure to welcome more than 80 delegates to our annual Endocrine Disruptors Conference in Cologne and via our Conference Live Stream.

Over two days, experts from industry, regulatory authorities, consultancies and research organisations discussed current developments and future directions in endocrine disruptor assessment. The mix of perspectives around the table sparked lively discussions throughout the conference, highlighting the value of open exchange between the different stakeholder groups.

Across presentations covering REACH, biocides, plant protection products, pharmaceuticals, packaging materials and CLP, speakers addressed topics ranging from hazard- versus risk-based approaches and regulatory implementation to advanced assessment tools and New Approach Methodologies (NAMs).

One theme that surfaced throughout many sessions was the challenge of translating complex scientific findings into clear and consistent regulatory decisions. Discussions repeatedly touched on how evidence is assessed and how assessments can be made as transparent and robust as possible.

The implementation of the new CLP hazard classes was another recurring topic, with several speakers exploring the practical challenges of distinguishing between Category 1 and Category 2 classifications and the questions this raises in relation to existing sector-specific frameworks.

Another strong focus was the development and application of innovative and animal-free approaches. While significant scientific progress is being made, several speakers highlighted the challenge of integrating new methods into existing regulatory processes.

While the formal programme came to an end, many conversations carried on into the evening. The dinner provided a welcome opportunity to continue discussions and meet new faces from across the ED community.

Our sincere thanks go to all participants, speakers and our conference co-chairs for contributing their expertise, questions and perspectives.


    Jetzt teilen


    Back